Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis

Detalhes bibliográficos
Autor(a) principal: Nery, Adriane de Lacerda
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UERJ
Texto Completo: http://www.bdtd.uerj.br/handle/1/14435
Resumo: Leishmaniasis are a group of diseases caused by protozoan of genus Leishmania spp affecting of 98 countries. In Brazil, in the year 2013 were 3.253 reported cases of visceral leishmaniasis and 18.226 cases of cutaneous leishmaniasis. The first choice of treatment is still performed with pentavalent antimonials and in cases of failures drugs of second line of treatment are pentamidine and anfotericin B. These drugs cause many adverse effects and has lately emerged resistant strains. In endemic areas it has been increasingly common the appearance of co-infection Leishmania and Mycobacterium tuberculosis. The treatment of tuberculosis with pyrazinamid and isoniazid control the leishmaniasis.The aim of this study was evaluate the anti-leishmania activity in vitro of INZ and PZA and yours derivatives compounds (serie G and serie R,respectively) on the Leishmania (Viannia) braziliensis. The molecules were tested on infected monolayers of peritoneal murine macrophages for 48h. All the molecules te inhibited the infection index in a dose-dependent manner in relation to controls. The molecules of the R series were more active than PZA, but the result was only significant for R02 (p < 0,005). Only R05 (CC50 = 76,64µM) was relatively toxic to macrophages. The most active compounds were R02, G01 and G02 whose select index were 14,31, 19 and 30, respectively. Nitrite assay was performed in supernatants of infected monolayers of peritonial macrophages treated with the substancies at 10 and 100µM. G01 and G02 stimulated NO2 prodution, however, the result was only statistically significant for G02 at 100µM (p < 0,001). All the compounds of R serie stimulated NO2 production however the results were statistically significant for the R03 and R05 at 100µM (p < 0,001). Additionally, a in silico preditive pharmacokinetic analysis was performed to active molecules using the admetSAR software the data showed that G01, G02 and R02 were similar to their original molecules as to high capacity to be absorbed by the gastrointestinal tract, low hepatotoxic and carcinogenic potencial. Together, these data demonstrate that these molecules are selectively toxic to the parasite with the potencial to be tested orally on studies in experimental infection.
id UERJ_64f186e510f8aef9c48820681acc1f13
oai_identifier_str oai:www.bdtd.uerj.br:1/14435
network_acronym_str UERJ
network_name_str Biblioteca Digital de Teses e Dissertações da UERJ
repository_id_str 2903
spelling Silva, Sílvia Amaral Gonçalves dahttp://lattes.cnpq.br/6104190112253764Dutra, Patrícia Maria Lourençohttp://lattes.cnpq.br/1617851661398279Lima, Wallace Pacienzahttp://lattes.cnpq.br/8474587392041059Manfro, Wânia Ferraz Pereirahttp://lattes.cnpq.br/5850137312836330http://lattes.cnpq.br/6770125945071237Nery, Adriane de Lacerda2021-01-07T15:16:35Z2015-09-302015-07-15NERY, Adriane de Lacerda. Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis. 2015. 55 f. Dissertação (Mestrado em Microbiologia Médica Humana) - Universidade do Estado do Rio de Janeiro, Rio de Janeiro, 2015.http://www.bdtd.uerj.br/handle/1/14435Leishmaniasis are a group of diseases caused by protozoan of genus Leishmania spp affecting of 98 countries. In Brazil, in the year 2013 were 3.253 reported cases of visceral leishmaniasis and 18.226 cases of cutaneous leishmaniasis. The first choice of treatment is still performed with pentavalent antimonials and in cases of failures drugs of second line of treatment are pentamidine and anfotericin B. These drugs cause many adverse effects and has lately emerged resistant strains. In endemic areas it has been increasingly common the appearance of co-infection Leishmania and Mycobacterium tuberculosis. The treatment of tuberculosis with pyrazinamid and isoniazid control the leishmaniasis.The aim of this study was evaluate the anti-leishmania activity in vitro of INZ and PZA and yours derivatives compounds (serie G and serie R,respectively) on the Leishmania (Viannia) braziliensis. The molecules were tested on infected monolayers of peritoneal murine macrophages for 48h. All the molecules te inhibited the infection index in a dose-dependent manner in relation to controls. The molecules of the R series were more active than PZA, but the result was only significant for R02 (p < 0,005). Only R05 (CC50 = 76,64µM) was relatively toxic to macrophages. The most active compounds were R02, G01 and G02 whose select index were 14,31, 19 and 30, respectively. Nitrite assay was performed in supernatants of infected monolayers of peritonial macrophages treated with the substancies at 10 and 100µM. G01 and G02 stimulated NO2 prodution, however, the result was only statistically significant for G02 at 100µM (p < 0,001). All the compounds of R serie stimulated NO2 production however the results were statistically significant for the R03 and R05 at 100µM (p < 0,001). Additionally, a in silico preditive pharmacokinetic analysis was performed to active molecules using the admetSAR software the data showed that G01, G02 and R02 were similar to their original molecules as to high capacity to be absorbed by the gastrointestinal tract, low hepatotoxic and carcinogenic potencial. Together, these data demonstrate that these molecules are selectively toxic to the parasite with the potencial to be tested orally on studies in experimental infection.As leishmanioses são um grupo de doenças causadas por protozoários do gênero Leishmania spp que afetam 98 países. No Brasil, no ano de 2013, foram relatados 3.253 casos de leishmaniose visceral e 18.226 casos de Leishmaniose Tegumentar Americana. O tratamento de primeira escolha continua sendo realizado com antimoniais pentavalentes, e em casos de insucessos os fármacos de segunda escolha são a pentamidina e a anfotericina B. Tais medicamentos causam intensos efeitos adversos e ultimamente têm surgido cepas resistentes aos mesmos. Em áreas endêmicas têm sido cada vez mais comum o surgimento da co-infecção Leishmania com Mycobacterium tuberculosis. O tratamento para a tuberculose com pirazinamida (PZA) e isoniazida (INZ), controla a leishmaniose. Esses dados sugerem atividade anti-leishmania da PZA e da INZ. O objetivo deste trabalho foi avaliar a atividade in vitro da INZ e da PZA e seus compostos derivados (série G e série R, respectivamente) sobre Leishmania (Viannia) braziliensis. As moléculas foram testadas em monocamadas de macrófagos peritoneais de camunongos infectados com L. (V) braziliensis durante 48h. Todas as moléculas testadas inibiram o índice de infecção de forma dose dependente em comparação aos controles. As moléculas da série R foram mais ativas do que a PZA, porém o resultado foi significativo somente para a R02 (p < 0,005). Apenas a molécula R05 (76,64µM) foi relativamente tóxica para macrófagos. Os compostos mais ativos foram R02, G01 e G02, cujos índices de seletividade foram 14,31, 19 e 30, respectivamente. A dosagem de nitrito foi feita em sobrenadantes de monocamadas de macrófagos peritoniais infectados e tratados com as substâncias nas concentrações 10 e 100µM. A G01 e a G02 estimularam a produção de NO2 nas duas concentrações, entretanto o resultado foi estatisticamente significativo para a G02 em 100µM (p < 0,0001), a G05 só estimulou óxido nítrico na maior concentração. Todos os compostos da série R estimularam NO2, contudo, o resultado foi estatisticamente significativo para a R03 e R05 a 100µM (p < 0,001). Adicionalmente, foi realizado uma análise preditiva in sílico de parâmetros farmacocinéticos das moléculas mais ativas in vitro, utilizando o software admetSAR. Os dados obtidos mostraram que de forma semelhante às suas moléculas originais a G01, G02 e R02 apresentaram alta capacidade de serem absorvidas pelo trato gastrointestinal, baixo potencial hepatotoxico e carcinogênico. Juntos, esses dados demonstram que essas moléculas são seletivamente tóxicas para o parasito com potencial para serem testadas pela via oral em estudos em modelo experimental de infecção.Submitted by Boris Flegr (boris@uerj.br) on 2021-01-07T15:16:35Z No. of bitstreams: 1 Adriane de Lacerda Nery Dissertacao completa.pdf: 1136047 bytes, checksum: 8b47244acd965d6576f2af2254091f0b (MD5)Made available in DSpace on 2021-01-07T15:16:35Z (GMT). No. of bitstreams: 1 Adriane de Lacerda Nery Dissertacao completa.pdf: 1136047 bytes, checksum: 8b47244acd965d6576f2af2254091f0b (MD5) Previous issue date: 2015-07-15Coordenação de Aperfeiçoamento de Pessoal de Nível Superiorapplication/pdfporUniversidade do Estado do Rio de JaneiroPrograma de Pós-Graduação em MicrobiologiaUERJBRCentro Biomédico::Faculdade de Ciências MédicasLeishmania (Viannia) braziliensisIsoniazid and PyrazinamideIn vitro activityLeishmania (Viannia) braziliensisIsoniazidaPirazinamidaAtividade in vitroLeishmania braziliensisIsoniazidaPirazinamidaTécnicas in vitroCNPQ::CIENCIAS BIOLOGICAS::PARASITOLOGIAEstudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensisIn vitro study of synthetic derivatives of isoniazid and pyrazinamide on the Leishmania (Viannia) braziliensisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UERJinstname:Universidade do Estado do Rio de Janeiro (UERJ)instacron:UERJORIGINALAdriane de Lacerda Nery Dissertacao completa.pdfapplication/pdf1136047http://www.bdtd.uerj.br/bitstream/1/14435/1/Adriane+de+Lacerda+Nery+Dissertacao+completa.pdf8b47244acd965d6576f2af2254091f0bMD511/144352024-02-26 19:54:40.502oai:www.bdtd.uerj.br:1/14435Biblioteca Digital de Teses e Dissertaçõeshttp://www.bdtd.uerj.br/PUBhttps://www.bdtd.uerj.br:8443/oai/requestbdtd.suporte@uerj.bropendoar:29032024-02-26T22:54:40Biblioteca Digital de Teses e Dissertações da UERJ - Universidade do Estado do Rio de Janeiro (UERJ)false
dc.title.por.fl_str_mv Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
dc.title.alternative.eng.fl_str_mv In vitro study of synthetic derivatives of isoniazid and pyrazinamide on the Leishmania (Viannia) braziliensis
title Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
spellingShingle Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
Nery, Adriane de Lacerda
Leishmania (Viannia) braziliensis
Isoniazid and Pyrazinamide
In vitro activity
Leishmania (Viannia) braziliensis
Isoniazida
Pirazinamida
Atividade in vitro
Leishmania braziliensis
Isoniazida
Pirazinamida
Técnicas in vitro
CNPQ::CIENCIAS BIOLOGICAS::PARASITOLOGIA
title_short Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
title_full Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
title_fullStr Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
title_full_unstemmed Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
title_sort Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis
author Nery, Adriane de Lacerda
author_facet Nery, Adriane de Lacerda
author_role author
dc.contributor.advisor1.fl_str_mv Silva, Sílvia Amaral Gonçalves da
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6104190112253764
dc.contributor.referee1.fl_str_mv Dutra, Patrícia Maria Lourenço
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/1617851661398279
dc.contributor.referee2.fl_str_mv Lima, Wallace Pacienza
dc.contributor.referee2Lattes.fl_str_mv http://lattes.cnpq.br/8474587392041059
dc.contributor.referee3.fl_str_mv Manfro, Wânia Ferraz Pereira
dc.contributor.referee3Lattes.fl_str_mv http://lattes.cnpq.br/5850137312836330
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/6770125945071237
dc.contributor.author.fl_str_mv Nery, Adriane de Lacerda
contributor_str_mv Silva, Sílvia Amaral Gonçalves da
Dutra, Patrícia Maria Lourenço
Lima, Wallace Pacienza
Manfro, Wânia Ferraz Pereira
dc.subject.eng.fl_str_mv Leishmania (Viannia) braziliensis
Isoniazid and Pyrazinamide
In vitro activity
topic Leishmania (Viannia) braziliensis
Isoniazid and Pyrazinamide
In vitro activity
Leishmania (Viannia) braziliensis
Isoniazida
Pirazinamida
Atividade in vitro
Leishmania braziliensis
Isoniazida
Pirazinamida
Técnicas in vitro
CNPQ::CIENCIAS BIOLOGICAS::PARASITOLOGIA
dc.subject.por.fl_str_mv Leishmania (Viannia) braziliensis
Isoniazida
Pirazinamida
Atividade in vitro
Leishmania braziliensis
Isoniazida
Pirazinamida
Técnicas in vitro
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::PARASITOLOGIA
description Leishmaniasis are a group of diseases caused by protozoan of genus Leishmania spp affecting of 98 countries. In Brazil, in the year 2013 were 3.253 reported cases of visceral leishmaniasis and 18.226 cases of cutaneous leishmaniasis. The first choice of treatment is still performed with pentavalent antimonials and in cases of failures drugs of second line of treatment are pentamidine and anfotericin B. These drugs cause many adverse effects and has lately emerged resistant strains. In endemic areas it has been increasingly common the appearance of co-infection Leishmania and Mycobacterium tuberculosis. The treatment of tuberculosis with pyrazinamid and isoniazid control the leishmaniasis.The aim of this study was evaluate the anti-leishmania activity in vitro of INZ and PZA and yours derivatives compounds (serie G and serie R,respectively) on the Leishmania (Viannia) braziliensis. The molecules were tested on infected monolayers of peritoneal murine macrophages for 48h. All the molecules te inhibited the infection index in a dose-dependent manner in relation to controls. The molecules of the R series were more active than PZA, but the result was only significant for R02 (p < 0,005). Only R05 (CC50 = 76,64µM) was relatively toxic to macrophages. The most active compounds were R02, G01 and G02 whose select index were 14,31, 19 and 30, respectively. Nitrite assay was performed in supernatants of infected monolayers of peritonial macrophages treated with the substancies at 10 and 100µM. G01 and G02 stimulated NO2 prodution, however, the result was only statistically significant for G02 at 100µM (p < 0,001). All the compounds of R serie stimulated NO2 production however the results were statistically significant for the R03 and R05 at 100µM (p < 0,001). Additionally, a in silico preditive pharmacokinetic analysis was performed to active molecules using the admetSAR software the data showed that G01, G02 and R02 were similar to their original molecules as to high capacity to be absorbed by the gastrointestinal tract, low hepatotoxic and carcinogenic potencial. Together, these data demonstrate that these molecules are selectively toxic to the parasite with the potencial to be tested orally on studies in experimental infection.
publishDate 2015
dc.date.available.fl_str_mv 2015-09-30
dc.date.issued.fl_str_mv 2015-07-15
dc.date.accessioned.fl_str_mv 2021-01-07T15:16:35Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv NERY, Adriane de Lacerda. Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis. 2015. 55 f. Dissertação (Mestrado em Microbiologia Médica Humana) - Universidade do Estado do Rio de Janeiro, Rio de Janeiro, 2015.
dc.identifier.uri.fl_str_mv http://www.bdtd.uerj.br/handle/1/14435
identifier_str_mv NERY, Adriane de Lacerda. Estudo in vitro de derivados sintéticos da Isoniazida e da Pirazinamida sobre Leishmania (Viannia) braziliensis. 2015. 55 f. Dissertação (Mestrado em Microbiologia Médica Humana) - Universidade do Estado do Rio de Janeiro, Rio de Janeiro, 2015.
url http://www.bdtd.uerj.br/handle/1/14435
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade do Estado do Rio de Janeiro
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Microbiologia
dc.publisher.initials.fl_str_mv UERJ
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Centro Biomédico::Faculdade de Ciências Médicas
publisher.none.fl_str_mv Universidade do Estado do Rio de Janeiro
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UERJ
instname:Universidade do Estado do Rio de Janeiro (UERJ)
instacron:UERJ
instname_str Universidade do Estado do Rio de Janeiro (UERJ)
instacron_str UERJ
institution UERJ
reponame_str Biblioteca Digital de Teses e Dissertações da UERJ
collection Biblioteca Digital de Teses e Dissertações da UERJ
bitstream.url.fl_str_mv http://www.bdtd.uerj.br/bitstream/1/14435/1/Adriane+de+Lacerda+Nery+Dissertacao+completa.pdf
bitstream.checksum.fl_str_mv 8b47244acd965d6576f2af2254091f0b
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UERJ - Universidade do Estado do Rio de Janeiro (UERJ)
repository.mail.fl_str_mv bdtd.suporte@uerj.br
_version_ 1792352329078407168